Loading resource…

Duke Cancer Institute, Durham, North Carolina, USA
As cancer survival rates improve, the incidence of cardiovascular complications related to cancer therapies has become a significant concern. This text discusses the cardiotoxic effects of various chemotherapeutic agents and radiation therapy, emphasizing the need for vigilant cardiovascular monitoring in cancer survivors. It includes guidelines for screening and management strategies to mitigate cardiovascular risks associated with cancer treatments.
No account needed